ASCO Presentations Indicate Bright Future For Immunotherapy

Jonathan C. Trent, MD, PhD, discusses data from 2 phase 2 trials of immunotherapy in soft tissue sarcoma, as well as their clinical significance.

Related Keywords

Florida , United States , Miami , University Of Miami , Jonathanc Trent , Breelyn Wilky , News Network , Sylvester Comprehensive Cancer Center , University Of Miami Miller School Medicine , Clinical Research , University Of Miami Health Syste , Miami Health , Miami Miller School , Sylvester Comprehensive Cancer , Sylvester , Disco , Soft Tissue Sarcoma ,